Remdesivir Intermediate CAS 946511-97-3 COVID-19 (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride
Manufacturer Commercial Supply Remdesivir and Related Intermediates with High Quality
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermediate CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Chemical Name | (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride |
Synonyms | Remdesivir Intermediate; L-Alanine 2-Ethylbutyl Ester Hydrochloride; Remdesivir Amino Ester Compound; Remdesivir Related Compound 8; Remdesivir Impurity 8 |
CAS Number | 946511-97-3 |
CAT Number | RF-PI298 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C9H20ClNO2 |
Molecular Weight | 209.71 |
Melting Point | 75.0 to 79.0℃ |
Sensitive | Hygroscopic |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Almost White Powder |
Loss on Drying | ≤1.0% |
Single Impurity | ≤0.50% |
Total Impurities | ≤1.0% |
Heavy Metals | ≤20ppm |
Purity | ≥99.0% |
Test Standard | Enterprise Standard |
Usage | Intermediate of Remdesivir (CAS 1809249-37-3); COVID-19 |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride (CAS 946511-97-3), it's typically used for the preparation of Remdesivir (CAS 1809249-37-3). Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences, with effective antiviral activity( EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells). In February 2020 Remdesivir was being studied for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.